Literature DB >> 33318165

Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?

Marinos C Dalakas1.   

Abstract

Year:  2020        PMID： 33318165     DOI： 10.1212/WNL.0000000000011349

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

Review 2.  Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.

Authors:  Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

3.  Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.

Authors:  Jessica Yi; Marinos C Dalakas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.